Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-19

Clinical Trial Update: Bladder Botox UTI Antibiotic Prophylaxis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating bladder botox (botulinum toxin A) for urinary tract infection prophylaxis in patients with overactive bladder or bladder pain syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Walter Reed National Military Medical Center | Conditions: Overactive Bladder, Bladder Pain Syndrome | Phase 4 | Status: RECRUITING